These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1286743)

  • 1. International symposium on the first steps towards an international harmonization of veterinary biologicals: 1993 and free circulation of vaccines within the E.E.C. Ploufragan, France, 14-16 January 1992. Proceedings.
    Dev Biol Stand; 1992; 79():1-224. PubMed ID: 1286743
    [No Abstract]   [Full Text] [Related]  

  • 2. The first steps towards an international harmonization of veterinary biologicals.
    Stewart-Tull D; Brown F
    Vaccine; 1993; 11(6):692-5. PubMed ID: 8322497
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of risk assessment to veterinary biologicals: the perspective of the animal health industry.
    Folkers C; Draayer HA; Verschueren C
    Rev Sci Tech; 1995 Dec; 14(4):1207-16. PubMed ID: 8639957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologicals: test procedures available to assess components and products, with limitations.
    Lee AM
    Rev Sci Tech; 1995 Dec; 14(4):1073-82. PubMed ID: 8639947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk analysis for veterinary biologicals released into the environment.
    Silva SV; Samagh BS; Morley RS
    Rev Sci Tech; 1995 Dec; 14(4):1043-59. PubMed ID: 8639945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the Office International des Epizooties in the standardisation of biologicals.
    Truszczynski M; Blancou J
    Dev Biol Stand; 1992; 79():95-8. PubMed ID: 1286770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international collaborative study on a method for determination of formaldehyde in veterinary vaccines.
    Ross PF; Draayer H; Itoh O
    Biologicals; 2002 Mar; 30(1):37-41. PubMed ID: 11846428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The procedure for marketing authorization for veterinary medicinal products derived from biotechnology in the European community.
    Brunko P
    Dev Biol Stand; 1992; 79():11-5. PubMed ID: 1286745
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk assessment related to veterinary biologicals: specific issues in developing nations.
    Ward DE
    Rev Sci Tech; 1995 Dec; 14(4):991-1007. PubMed ID: 8639967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current USDA procedures for licensing biotechnology-derived veterinary biologicals.
    Gay CG
    Dev Biol Stand; 1992; 79():65-74. PubMed ID: 1286767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The American manufacturer's view on the EEC texts and harmonization.
    Draayer HA; Hilsabeck LJ; Miller RH
    Dev Biol Stand; 1992; 79():77-83. PubMed ID: 1286768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Veterinary pharmacy and the European Economic Community].
    Ruijgh C
    Tijdschr Diergeneeskd; 1989 May; 114(10):595-6. PubMed ID: 2734772
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory framework of immunologicals in the European Union.
    Sauer F
    Biologicals; 1994 Dec; 22(4):307-11. PubMed ID: 7779353
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings of the 1st International Symposium on Risk Assessment for Veterinary Biologicals: The Next Step in International Harmonisation. Arlington, Virginia, 5-7 December 1994.
    Rev Sci Tech; 1995 Dec; 14(4):903-1220. PubMed ID: 8639959
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of international and regional organisations in the regulation of veterinary biologicals.
    Blancou J; Truszczynski M
    Rev Sci Tech; 1995 Dec; 14(4):1193-206. PubMed ID: 8639956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO Expert Committee on Biological Standardization.
    World Health Organ Tech Rep Ser; 2002; 910():1-104, back cover. PubMed ID: 15497598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of risk assessments for biologicals or related products in the European Union.
    Moos M
    Rev Sci Tech; 1995 Dec; 14(4):1009-20. PubMed ID: 8639943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings and abstracts of the First International Conference of the OIE Reference Laboratories and Collaborating Centers, 3-5 December 2006, Floranopolis, Brazil.
    Dev Biol (Basel); 2007; 128():1-177. PubMed ID: 18213900
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk analysis for the importation of veterinary biologicals into the United States of America.
    Roth HJ; Gay CG; Espeseth DA
    Rev Sci Tech; 1995 Dec; 14(4):1061-72. PubMed ID: 8639946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.